BIOLASE (BIOL) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock BIOL vs. LGMK, BJDX, DYNT, IONM, TTOO, SDCCQ, GMVDF, AFIB, VRAYQ, and SONXShould you be buying BIOLASE stock or one of its competitors? The main competitors of BIOLASE include LogicMark (LGMK), Bluejay Diagnostics (BJDX), Dynatronics (DYNT), Assure (IONM), T2 Biosystems (TTOO), SmileDirectClub (SDCCQ), G Medical Innovations (GMVDF), Acutus Medical (AFIB), ViewRay (VRAYQ), and Sonendo (SONX). These companies are all part of the "medical equipment" industry. BIOLASE vs. Its Competitors LogicMark Bluejay Diagnostics Dynatronics Assure T2 Biosystems SmileDirectClub G Medical Innovations Acutus Medical ViewRay Sonendo BIOLASE (NASDAQ:BIOL) and LogicMark (NASDAQ:LGMK) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, dividends, risk, profitability, analyst recommendations, media sentiment, earnings and institutional ownership. Do insiders and institutionals hold more shares of BIOL or LGMK? 8.8% of BIOLASE shares are owned by institutional investors. Comparatively, 7.9% of LogicMark shares are owned by institutional investors. 0.3% of BIOLASE shares are owned by insiders. Comparatively, 2.2% of LogicMark shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has stronger valuation and earnings, BIOL or LGMK? LogicMark has lower revenue, but higher earnings than BIOLASE. LogicMark is trading at a lower price-to-earnings ratio than BIOLASE, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBIOLASE$48.83M0.00-$20.63M-$14.94N/ALogicMark$9.88M0.20-$14.55M-$223.500.00 Does the media favor BIOL or LGMK? In the previous week, LogicMark had 2 more articles in the media than BIOLASE. MarketBeat recorded 2 mentions for LogicMark and 0 mentions for BIOLASE. LogicMark's average media sentiment score of 0.59 beat BIOLASE's score of 0.00 indicating that LogicMark is being referred to more favorably in the news media. Company Overall Sentiment BIOLASE Neutral LogicMark Positive Which has more risk & volatility, BIOL or LGMK? BIOLASE has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500. Comparatively, LogicMark has a beta of 1.57, indicating that its share price is 57% more volatile than the S&P 500. Is BIOL or LGMK more profitable? BIOLASE has a net margin of -41.65% compared to LogicMark's net margin of -141.96%. LogicMark's return on equity of -124.91% beat BIOLASE's return on equity.Company Net Margins Return on Equity Return on Assets BIOLASE-41.65% -1,782.73% -55.31% LogicMark -141.96%-124.91%-92.05% Do analysts prefer BIOL or LGMK? BIOLASE presently has a consensus target price of $0.40, suggesting a potential upside of 0.00%. Given BIOLASE's stronger consensus rating and higher possible upside, analysts clearly believe BIOLASE is more favorable than LogicMark.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BIOLASE 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00LogicMark 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryBIOLASE beats LogicMark on 8 of the 15 factors compared between the two stocks. Get BIOLASE News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIOL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIOL vs. The Competition Export to ExcelMetricBIOLASEDental equipment & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$581K$21K$5.76B$9.92BDividend YieldN/AN/A6.67%4.52%P/E Ratio0.00N/A75.6026.68Price / SalesN/A0.00538.82209.12Price / CashN/AN/A37.1158.92Price / BookN/A0.0011.446.09Net Income-$20.63M-$60.92M$3.28B$266.14M BIOLASE Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOLBIOLASEN/AN/A$0.40+∞N/A$581K$48.83M0.00160LGMKLogicMark0.8153 of 5 stars$0.00+2.8%N/A-99.9%$2.13M$9.88M0.0020News CoverageGap UpBJDXBluejay Diagnostics0.3182 of 5 stars$1.36-0.6%N/A-81.8%$2.03M$250K-0.019News CoveragePositive NewsShort Interest ↑DYNTDynatronicsN/A$0.09-1.6%N/A-47.5%$1.18M$33.60M-0.11200Gap DownIONMAssureN/A$0.05flatN/AN/A$150K$149K0.00130TTOOT2 BiosystemsN/A$0.00+42.9%N/A-99.6%$84K$7.68M0.00180Gap UpSDCCQSmileDirectClubN/A$0.00-50.0%N/AN/A$40K$470.74M0.002,700Gap DownGMVDFG Medical InnovationsN/AN/AN/AN/A$26K$4.42M0.0072AFIBAcutus MedicalN/A$0.00+60.0%N/A-98.9%$24K$7.16M0.00340Gap UpVRAYQViewRayN/A$0.00+∞N/AN/A$18K$102.21M0.00300Gap UpHigh Trading VolumeSONXSonendoN/A$0.03flatN/A-37.0%$13K$44.40M0.00250 Related Companies and Tools Related Companies LogicMark Alternatives Bluejay Diagnostics Alternatives Dynatronics Alternatives Assure Alternatives T2 Biosystems Alternatives SmileDirectClub Alternatives G Medical Innovations Alternatives Acutus Medical Alternatives ViewRay Alternatives Sonendo Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIOL) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BIOLASE, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BIOLASE With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIOL Stock Alerts